Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Antipsychotics
Dementia’s Behavioral Changes: A Psychiatrist Explains
FDA Approves the First Drug for Alzheimer’s Agitation: Rexulti
Managing the Behavioral Symptoms of Dementia: A BrainTalk With Dr. Dylan Wint
Now Under FDA Review: Potential First Treatment for Dementia-Related Psychosis
Researchers Study Potential Side Effects of Medications for People with Alzheimer’s
75% of Older Adults With Dementia May Be On the Wrong Prescriptions
A New Drug for Agitation in Alzheimer’s Progresses Through Trials
Looking Beyond Drugs to Treat Aggression in Dementia Patients
Antipsychotic Drugs Linked to More Hospitalizations Among Dementia Patients
Antipsychotics Make No Difference for Delirium or Dementia in the I.C.U.
‘Chemical Restraints’: Report Finds Nursing Homes Misuse Antipsychotics
Page load link
Go to Top
